NCT04710316View on ClinicalTrials.gov

Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

September 30, 2022

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 screening by molecular biology

SARS-CoV-2 RT-PCR in nasopharyngeal swab targeting 2 regions of the viral genome

DIAGNOSTIC_TEST

Serological screening

Serological screening of caregivers at D0, M1, M2, M3 (anti-nucleocapsid antibodies).

Trial Locations (4)

Unknown

Hopital du Point-G, Bamako

Hopital Gabriel Toure, Bamako

Hôpital dermatologique de Bamako, Bamako

Hôpital du Mali, Bamako

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT04710316 - Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali | Biotech Hunter | Biotech Hunter